Who has invested in SmithRx?

Venrock are named among the investors backing SmithRx.

SmithRx Funding: $80M Raised, Series C (2024)

SmithRx funding overview

SmithRx is a Healthtech company based in San Francisco. SmithRx has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2024. The round record for SmithRx runs through 2024; nothing later has been disclosed. Investors on record include Venrock.

SmithRx at a glance

Total raised: $80M
Latest round: Series C
Latest round date: January 2024
Industry: Healthtech
Headquarters: San Francisco
Notable investors: Venrock

Frequently asked about SmithRx funding

How much has SmithRx raised?: SmithRx has raised $80M in total disclosed funding across the rounds on record.
Who has invested in SmithRx?: Venrock are named among the investors backing SmithRx.
What was the latest SmithRx funding round?: The most recent disclosed round is a Series C, announced in January 2024.
Where is SmithRx based?: SmithRx is based in San Francisco.
What sector does SmithRx operate in?: SmithRx is tracked under Healthtech from San Francisco, with $80M in disclosed funding.
When did SmithRx last raise?: The last disclosed SmithRx round closed in January 2024 at Series C.

Totals shown for SmithRx aggregate every disclosed round on file. To see how that compares, browse the Healthtech companies in San Francisco and the investors behind them below.

SmithRx Funding: $80M Raised, Series C (2024)

SmithRx funding overview

SmithRx at a glance

Frequently asked about SmithRx funding

SmithRx founders (1)

Companies related to SmithRx (40)

Browse related funding lists (6)